Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The brain extracellular matrix (ECM) is a specialized network of macromolecules, including proteoglycans, glycoproteins, and glycosaminoglycans, that occupies the space between neural cells. Unlike the fibrous ECM in peripheral tissues, the brain ECM is rich in hyaluronic acid and lecticans, often forming condensed structures known as perineuronal nets that stabilize adult synapses and restrict plasticity (Dityatev et al., 2010, Nature Reviews Neuroscience). Remodeling enzymes, such as matrix metalloproteinases (MMPs) and ADAMTS proteases, are responsible for the dynamic turnover of these components, a process essential for learning, memory, and recovery from injury (Bonneh-Barkay & Wiley, 2009, Brain Pathology). Dysregulation of this balance is a hallmark of several neurological conditions; for instance, excessive MMP activity contributes to blood-brain barrier breakdown in stroke, while the accumulation of inhibitory proteoglycans prevents axonal regeneration after spinal cord injury (Lau et al., 2013, Nature Reviews Neuroscience). Pharmacological interventions typically aim to either inhibit degradative enzymes to preserve tissue integrity or utilize exogenous enzymes like chondroitinase ABC to dissolve inhibitory scars and restore functional plasticity (Zimmermann & Dours-Zimmermann, 2008, Histochemistry and Cell Biology).
Inhibition of matrix metalloproteinases (MMPs) to prevent tissue degradation; Enzymatic digestion of chondroitin sulfate proteoglycans to promote plasticity; Modulation of integrin-mediated signaling.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain extracellular matrix proteins and remodeling enzymes (Brain ECM).